1. (2)JL Abbruzzese, A Rosenberg, Q Xiong, A LoBuglio, W Schmidt, R Wolff, M Needle, and H Waskal : Phase II study of anti-epidermal growth factor receptor (EGFR) antibody cetuximab (IMC-C225) in combination with gemcitabine in patients with advanced pancreatic cancer. Proceedings of the American Society of Clinical Oncology Meeting, 2001, 518, p 130a.
2. Chemotherapy for pancreatic carcinoma
3. Role for CD40âCD40 ligand interactions in the immune response to solid tumours
4. (5)G Anether, I Marschitz, I Tinhofer, and R Greil : IL-15 a potential costimulatory cytokine in CD154 gene therapy of CLL. Blood 2001 (in press).